Towa Pharmaceutical Co Ltd

Towa Pharmaceutical discloses a basic approach to keeping its trade-association work broadly consistent with its climate goals, stating that it is a member of "æ - ¥æœ¬ã‚¸ã‚§ãƒãƒªãƒƒã‚¯è£½è - ¬å"会（JGA）" and that "å½"ç¤¾ã‹ã‚‰ã®å‚åŠ ãƒ¡ãƒ³ãƒãƒ¼ã¯JGAのç'°å¢ƒå§"å"¡ä¼šå§"å"¡é•·ã‚'務め、æ - ¥è - ¬é€£ã®ç'°å¢ƒå§"å"¡ä¼šã¨å"åƒã§ã‚«ãƒ¼ãƒœãƒ³ãƒ‹ãƒ¥ãƒ¼ãƒˆãƒ©ãƒ«ã¸ã®å - 組や廃棄物の削減等のデータの収集、æƒ...å ±æä¾›ç­‰ã®æŽ¨é€²ã«åŠªã‚ã¦ã„ã¾ã™." This indicates the company is actively using its position within the association to promote carbon-neutral initiatives, suggesting some effort to align indirect lobbying with its own climate commitment to "2030年時点のグルーム- å...¨ä½"のScope1,2のæŽ'出量ã‚'30ï¼...削減" under the Japan Business Federation's "カーボンニュートラル行動計ç"»." However, the disclosure does not describe any formal governance mechanism - there is no explanation of how lobbying positions are reviewed, no description of monitoring procedures, and no identification of a board committee or senior executive responsible for overseeing lobbying alignment. As such, while the company acknowledges climate-related engagement through an industry body, it provides only limited evidence of a structured lobbying-governance framework.